VEGFR2/CD309 Antikörper (AA 1020-1069)
Kurzübersicht für VEGFR2/CD309 Antikörper (AA 1020-1069) (ABIN1532661)
Target
Alle VEGFR2/CD309 (VEGFR2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1020-1069
-
Spezifität
-
VEGFR2 Antibody detects endogenous levels of total VEGFR2 protein.
-
Aufreinigung
- The antibody was purified from rabbit antiserum by affinity-chromatography using immunogen.
-
Reinheit
- > 95 %
-
Immunogen
- The antiserum was produced against synthesized peptide derived from human VEGFR2.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IHC: 1:50~1:100 IF: 1:100~1:500 ELISA: 1:40000
-
Kommentare
-
Unigene-Number: Hs.479756, Hs.646917 (NCBI Gene Symbol: KDR)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable at -20°C for at least 1 year.
-
Haltbarkeit
- 12 months
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Andere Bezeichnung
- VEGFR2
-
Hintergrund
-
Synonyms: FLK1, KDR, kinase insert domain receptor, protein-tyrosine kinase receptor Flk-1, vascular endothelial growth factor receptor 2, VGFR2, VGR2
NCBI Gene Symbol: KDR
-
Molekulargewicht
- 151 kDa
-
Gen-ID
- 3791, 2324
-
OMIM
- 191306
-
UniProt
- P35968, P35916
-
Pathways
- RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-